Nakayama T, Nagai Y, Uehara Y, Nakamura Y, Ishii S, Kato H, Tanaka Y
Division of Metabolism and Endocrinology, Department of Internal Medicine, St Marianna University School of Medicine, Kawasaki, Japan.
Nutr Diabetes. 2017 May 8;7(5):e273. doi: 10.1038/nutd.2017.26.
We recently reported that eating glutinous brown rice (GBR) for 1 day improved the whole-day glucose profile and postprandial plasma glucose level compared with eating white rice (WR) or standard brown rice. However, it was unknown whether eating GBR could maintain improvement of glycemic control for a longer period. Therefore, we evaluated the effect of GBR intake for 8 weeks on glycemic control in outpatients with diabetes mellitus.
This was an open-label randomized crossover study in outpatients with type 2 diabetes. Among the 18 subjects registered in this study, 2 were excluded from analysis. After a 1-week observation period while eating WR twice a day, the patients were randomly assigned to two groups. One group ate GBR as a staple food twice a day for 8 weeks and then switched to WR for the next 8 weeks, while the other group ate WR first and then switched to GBR. A mixed meal tolerance test was performed at baseline and after 8 and 16 weeks of dietary intervention to evaluate plasma glucose and serum C-peptide.
None of the subjects failed to complete the study because of disliking the taste of GBR. Hemoglobin A1c (7.5-7.2%, P=0.014) and glycoalbumin (20.4-19.4%, P=0.029) both decreased significantly when the patients were eating GBR. Additionally, the 30-min postprandial plasma glucose level (194-172 mg dl, P=0.031) and the incremental area under the concentration vs time curve of serum C-peptide (31.3-22.1 ng min ml, P=0.023) during the mixed meal tolerance test were also decreased significantly by intake of GBR. In contrast, there were no changes of glycemic control during the WR period.
We confirmed that GBR was well tolerated for 8 weeks and improved glycemic control in patients with type 2 diabetes.
我们最近报告称,与食用白米(WR)或标准糙米相比,食用1天的糯糙米(GBR)可改善全天血糖状况及餐后血浆葡萄糖水平。然而,尚不清楚食用GBR是否能在更长时间内维持血糖控制的改善效果。因此,我们评估了8周内摄入GBR对糖尿病门诊患者血糖控制的影响。
这是一项针对2型糖尿病门诊患者的开放标签随机交叉研究。在本研究登记的18名受试者中,2名被排除在分析之外。在每天食用两次WR的1周观察期后,患者被随机分为两组。一组每天两次将GBR作为主食食用8周,然后在接下来的8周改用WR,而另一组先食用WR,然后改用GBR。在基线以及饮食干预8周和16周后进行混合餐耐量试验,以评估血浆葡萄糖和血清C肽。
没有受试者因不喜欢GBR的味道而未能完成研究。当患者食用GBR时,糖化血红蛋白(从7.5%降至7.2%,P = 0.014)和糖化白蛋白(从20.4%降至19.4%,P = 0.029)均显著下降。此外,在混合餐耐量试验期间,餐后30分钟血浆葡萄糖水平(从194毫克/分升降至172毫克/分升,P = 0.031)以及血清C肽浓度-时间曲线下的增量面积(从31.3纳克·分钟/毫升降至22.1纳克·分钟/毫升,P = 0.023)也因摄入GBR而显著下降。相比之下,在食用WR期间,血糖控制没有变化。
我们证实,GBR在8周内耐受性良好,并改善了2型糖尿病患者的血糖控制。